An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Detalles Bibliográficos
Autor principal:	Bristy, Israt Zerin
Otros Autores:	Kabir, Md. Tanvir
Formato:	Tesis
Lenguaje:	English
Publicado:	Brac University 2021
Materias:	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs > Cancer Oncology
Acceso en línea:	http://hdl.handle.net/10361/15619

id	10361-15619
record_format	dspace
spelling	10361-156192021-11-17T21:01:26Z An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma Bristy, Israt Zerin Kabir, Md. Tanvir Department of Pharmacy, Brac University Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs--Cancer Oncology This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 64-92). During the COVID-19 disease outbreak, the main objective of lung carcinoma treatment is to reduce the risk of contamination to patients and workers while simultaneously controlling all life-threatening elements of the illness. The pathophysiology of the development of lung cancer includes multiple genetic mutations, chromosomal abnormalities, and the presence of viruses. Nucleic acid SARS-CoV-2 detection & nasopharyngeal swab is used in the diagnosis of COVID-19 as well as an image-guided biopsy low-dose computed tomography is utilized for lung cancer identification. Furthermore, the challenging task of the management of chemotherapy, immunotherapy, therapeutic objectives, or optimal support services should be adjusted to the tumour types of the patient, the biomarkers, taking into consideration the risk of adverse effects and the potential of COVID-19 contamination. So, the overall treatment strategy of these patients is very prudent to avoid any further delay that could compromise survival with the challenges they are facing now. Israt Zerin Bristy B. Pharmacy 2021-11-17T05:48:08Z 2021-11-17T05:48:08Z 2021 2021-09 Thesis ID 17346053 http://hdl.handle.net/10361/15619 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 92 pages application/pdf Brac University
institution	Brac University
collection	Institutional Repository
language	English
topic	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs--Cancer Oncology
spellingShingle	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs--Cancer Oncology Bristy, Israt Zerin An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
description	This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
author2	Kabir, Md. Tanvir
author_facet	Kabir, Md. Tanvir Bristy, Israt Zerin
format	Thesis
author	Bristy, Israt Zerin
author_sort	Bristy, Israt Zerin
title	An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
title_short	An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
title_full	An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
title_fullStr	An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
title_full_unstemmed	An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
title_sort	overview of the clinical management and challenges of treatments for the patients diagnosed with covid-19 and lung carcinoma
publisher	Brac University
publishDate	2021
url	http://hdl.handle.net/10361/15619
work_keys_str_mv	AT bristyisratzerin anoverviewoftheclinicalmanagementandchallengesoftreatmentsforthepatientsdiagnosedwithcovid19andlungcarcinoma AT bristyisratzerin overviewoftheclinicalmanagementandchallengesoftreatmentsforthepatientsdiagnosedwithcovid19andlungcarcinoma
_version_	1814307271059963904

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

Ejemplares similares